Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Atrogi AB
AB
Active
Org 5569258311
Tomtebodavägen 6, 171 65
Solna
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2013 · 13 years old
14 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Atrogi AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PB
Paul Brian Little
Chief Executive Officer
Chief Executive Officer
2025
KN
Kent Niklas Jonsson
Chief Auditor
Chief Auditor
2022
Former (2)
BU
Björn Uno Bernhard Westberg
Chief Executive Officer
Chief Executive Officer
2025 – 2025
AK
Alexandra Kristina Ryding
Chief Executive Officer
Chief Executive Officer
2022 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (9)
MG
Mattias Giovanni Fili
Board of Directors
Board of Directors
2022
AO
Anders Olof Adolf Ekblom
Chairman
Chairman
2022
JA
Jan Arvid Söderhäll
Board of Directors
Board of Directors
2026
RS
Robert Sven Christer Taflin
Board of Directors
Board of Directors
2022
CS
Carl-Johan Spak
Board of Directors
Board of Directors
2022
TB
Tore Bengtsson
Board of Directors
Board of Directors
2022
RG
Roger Glen Berlin
Board of Directors
Board of Directors
2022
SL
Sangwoo Lee
Board of Directors
Board of Directors
2022
MD
Maarten De Chateau
Board of Directors
Board of Directors
2022
Former (1)
ÅI
Åsa Inde
Board of Directors
Board of Directors
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Atrogi AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network